Kratom use in the United States: Response to Grundmann et al

Addiction. 2021 Jan;116(1):203-204. doi: 10.1111/add.15170. Epub 2020 Jul 14.

Authors

Jonathan Schimmel^{1

2}, Elise Amioka¹, Karilynn Rockhill¹, Colleen M Haynes¹, Joshua C Black¹, Richard C Dart¹, Janetta L Iwanicki¹

Affiliations

¹ Rocky Mountain Poison and Drug Safety, Denver Health and Hospital Authority, Denver, CO, USA.
² Department of Emergency Medicine, Division of Medical Toxicology, Mount Sinai Hospital Icahn School of Medicine, New York, NY, USA.

PMID: 32588454
DOI: 10.1111/add.15170

No abstract available

Keywords: Drug abuse; NMURx; United States; epidemiology; kratom; mitragyna; mitragynine; opioid; prevalence.

Publication types

Letter
Comment

MeSH terms

Cross-Sectional Studies
Humans
Mitragyna*
Prevalence
Substance Withdrawal Syndrome*
United States